pharmacodynamic overlap possible via shared antioxidant pathways Primary concern / IV glutathione and liver-enzyme monitoring in patients on dulaglutide Monitoring recommended / LFTs at baseline and periodically when adding high-dose IV glutathione Evidence gap / no randomized controlled trial has tested the combination directly GLP-1 antioxidant effect / dulaglutide independently reduces oxidative stress markers in human studies Key guideline / ADA Standards of Care 2024 does not list glutathione as contraindicated with GLP-1 agents Bottom line / low-dose oral glutathione appears safe
If swelling becomes pronounced or is accompanied by other symptoms like shortness of breath, immediate medical evaluation is necessary
doi: 10.1016/S2215-0366(21)00395-3, 51 GiovannoniF.QuintanaF
Studies using APP/PS1 micea well-established model of Alzheimer's pathologydemonstrate that Dihexa administration restored spatial learning and cognitive functions to near-wildtype levels as measured by Morris water maze performance
[DOI] [PMC free article] [PubMed] [Google Scholar] 12.van Bloemendaal L., Veltman D.J., ten Kulve J.S., et al
Proteases, enzymes that break down proteins, are also released during degranulation
